Moderna

Moderna, Inc., is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule... Wikipedia

• Formerly called:  ModeRNA Therapeutics, (2010–2018)
• Type:  Public
• Traded as:  NASDAQ: mrna MRNA, Nasdaq-100 component, S&P 500 component
• ISIN:  [ US60770K1079]
• Industry:  Biotechnology
• Founders:  Derrick Rossi, Timothy A. Springer, Robert S. Langer, Kenneth R. Chien, Noubar Afeyan
• Key people:  Stéphane Bancel, CEO, Stephen Hoge, President, David Meline, CFO, Noubar Afeyan, Chairman, Robert S. Langer, Director, Paul Sagan, Director
• Products:  SpikeVax, Vaccine candidates
• Revenue:  US$803 million (2020)
• Operating income:  US$ −763 million (2020)
• Total assets:  US$7.336 billion (2020)
• Total equity:  US$2.561 billion (2020)
• Owner:  Noubar Afeyan (12.7%), Stéphane Bancel (7.9%), Robert S. Langer (2.9%), Stephen Hoge (1.3%)
• Number of employees:  2,500 (2021)
• Website:  modernatx.com
• Data source:  DuckDuckGo